---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-025396"
form_type: "8-K/A"
ticker: "VVOS"
cik: "0001716166"
company_name: "Vivos Therapeutics, Inc."
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:15:57.686817+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Vivos closes Sleep Center of Nevada acquisition for $6M cash + stock; issues $8.25M note

## Summary
- Acquired operating assets of SCN for $6M cash, 607k restricted shares ($1.5M at VWAP), plus contingent earn-out of up to $1.5M in stock.
- Wholly-owned AIM subsidiary signed 15-year PAAs with SCN ($200k/mo fee) and SCN PLLC ($100k/mo fee) to manage practice in compliance with CPM laws.
- Issued $8.25M secured promissory note to Streeterville Capital to finance the acquisition; AIM membership interests pledged as collateral.
- Integration of two of seven SCN locations underway; deploying 1.5 SO teams currently, targeting 4.5 teams by Q1 2026; patient demand exceeds capacity.
- SCN revenue expected in Q2 fiscal 2025; risk factors note unproven model, CPM law compliance, and debt service obligations.

## SEC filing metadata
- accession: 0001641172-25-025396
- form_type: 8-K/A
- ticker: VVOS
- cik: 0001716166
- company_name: Vivos Therapeutics, Inc.
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 9.01, 1.01, 2.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716166/000164117225025396/0001641172-25-025396-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716166/000164117225025396/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-025396
- JSON: https://secwatch.observer/filing/0001641172-25-025396.json
- Plain text: https://secwatch.observer/filing/0001641172-25-025396.txt

## Key facts
- M&A Transactions
  Vivos Therapeutics, Inc. completed an acquisition involving The Sleep Center of Nevada (SCN) (closed 2025-06-10).
  - Action: acquisition
  - Counterparty: The Sleep Center of Nevada (SCN)
  - Closing: 2025-06-10
  source text: On June 10, 2025, the Company completed the Acquisition, and the Company had acquired all of the operating assets of the Seller in consideration for a (i) cash payment equal to $6.0 million, (ii) 607,287 shares of restricted common stock in the Company, par value $0.0001 per share (the “ Common Stock ”), equal to $1.5 million based on the volume-weighted average price (“ VWAP ”) of the Common Stock for the 30 days immediately preceding the Acquisition and (iii) the assumption of certain specific trade accounts payable and liabilities related to specific SCN contracts assigned to the Company as part of the Acquisition.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716166/000164117225025396/0001641172-25-025396-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.